Dr Mansukh Mandaviya inspects Jan Aushadhi Kendra in Dehradun

Mandaviya said that both Central and State Governments are vigilant with regard to the quality of medicines manufactured and any company compromising with the drug manufacturing standards will not be spared.

Published On 2023-04-01 08:30 GMT   |   Update On 2023-04-11 10:09 GMT

New Delhi: Dr Mansukh Mandaviya, Union Minister for Health and Family Welfare and Chemicals and Fertilizers inspected the Jan Aushadhi Kendra located in Dehradun. During inspection, he interacted with the health workers at the Jan Aushadhi Kendra and the beneficiaries of the Jan Aushadhi Kendra.

During this, the Union Health Minister said that the Prime Minister is determined to provide cheap and accessible medicines to the common people. He said that no one should die due to lack of medicine, for this purpose the plan to open Jan Aushadhi Kendra has been brought.

He said that common people are getting relief and convenience by getting cheap medicines in Jan Aushadhi Kendra and people's trust on Jan Aushadhi Kendra has also increased. The Union Minister said that along with the need of the people, the medicines available at the Jan Aushadhi Kendra are also helping them save money.

He told that more than nine and a half thousand Jan Aushadhi Kendras are being operated across the country from the capital to the district headquarters at various places. About 20 lakh people visit Jan Aushadhi Kendra daily.

Advertisement

Dr Mansukh Mandaviya said that a cancer medicine Bicalutamide which is available in the market for Rs.800 is sold at Jan Aushadhi Kendra for only Rs.137. Another drug, Sitagliptin, is available in the market for Rs 400 while it's price at any Jan Aushadhi Kendra is only Rs 60.

Union Health Minister Dr. Mansukh Mandaviya said that pharmaceutical is an issue related to public health. He added that both Central and State Governments are vigilant with regard to the quality of medicines manufactured and any company compromising with the drug manufacturing standards will not be spared.

The minister said that regular inspection is carried out both by DCGI and State Drug Controllers all over the country and suitable action is taken against defaulters.

Read also: Need to shift to profit model through enhancing RnD capacities in pharma sector, says Mansukh Mandaviya

Tags:    

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News